Published October 16, 2017
American Heart Association
Atrial Fibrillation Strategically Focused Research Network. Complete Guidelines can be found at Am. Heart Association-Atrial Fibrillation-Strategically Focused Research Network
This Strategically Focused Research Network provides the AHA with a mechanism to enhance the understanding of the causes, biology, pathophysiology and epidemiology of Atrial Fibrillation, and to develop more effective ways to prevent and treat it with an ultimate improvement in patient outcomes. Testing effective methods for such improvement in outcomes will be provided by special funding from PCORI and the AHA.
In brief, there is a large proportion of individuals with AFib who are not prescribed appropriate long-term oral anticoagulation (OAC) therapy, despite the fact that OAC is understood to reduce the risk of stroke associated with AFib by >60%. The DECIDE Center will support the creation or adaptation of decision tools, validate them, and directly compare and evaluate shared decision-making tools and approaches in patients with atrial fibrillation and their clinicians, using comparative effectiveness research to address this important gap in evidence-based therapy.
The Atrial Fibrillation Strategically Focused Research Network will be comprised of four (4) AHA Center grants and one (1) PCORI – AHA/ASA Collaborative: Decision-making and Choices to Inform Dialogue and Empower A-Fib Patients (DECIDE) Center grant. Awards will be selected based on merit.
The maximum budget amount an AHA Center applicant may request is $3,709,200. The maximum budget amount the PCORI – AHA/ASA Collaborative: Decision-making and Choices to Inform Dialogue and Empower A-Fib Patients (DECIDE) Center applicant may request is $5,000,000.
Due to the limited number of applications, if you or your colleagues are interested in applying, please submit the internal review documents to Kenneth Tramposch at email@example.com by Nov. 3, 2017.
The internal review documents are:
If you are selected, the full proposal would be due Jan. 31, 2018.